International Clinical Trial: Efficacy and safety study of Iparomlimab and Tuvonalimab Injection in combination with chemotherapy in the neoadjuvant treatment of locally advanced cervical cancer: a single-center, single-arm, phase II trial

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118183) titled 'Efficacy and safety study of Iparomlimab and Tuvonalimab Injection in combination with chemotherapy in the neoadjuvant treatment of locally advanced cervical cancer: a single-center, single-arm, phase II trial' on Feb. 3.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Fudan University Shanghai Cancer Center

Condition: Cervical cancer

Recruitment Status: Recruiting

Phase: 2

Date of First Enrollment: 2025-05-07

Target Sample Size: Experimental group:47;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=274303

Disclaimer: Cura...